He Tian
- Topics
- RNA modifications and cancer (7 papers)MicroRNA in disease regulation (5 papers)Cancer-related molecular mechanisms research (5 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
He Tian
34 papers receiving 358 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 194
- Cancer Research 94
- Pulmonary and Respiratory Medicine 68
- Oncology 55
- Immunology 50
Countries citing papers authored by He Tian
This map shows the geographic impact of He Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Tian more than expected).
Fields of papers citing papers by He Tian
This network shows the impact of papers produced by He Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Tian. The network helps show where He Tian may publish in the future.
Co-authorship network of co-authors of He Tian
This figure shows the co-authorship network connecting the top 25 collaborators of He Tian. A scholar is included among the top collaborators of He Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Tian. He Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 25 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 8 | |
| 8 | 10 | |
| 9 | 11 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 17 | |
| 13 | 7 | |
| 14 | 15 | |
| 15 | 1 | |
| 16 | Gentiopicroside inhibits cancer cell growth in OVCAR-3 ovary cancer cells through the mediation of apoptosis, loss of mitochondrial transmembrane potential and NF-kB signalling pathway. | 4 |
| 17 | 31 | |
| 18 | 24 | |
| 19 | 24 | |
| 20 | 6 |
About He Tian
He Tian is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 35 papers that have together received 363 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (94 citations), Molecular Biology (194 citations) and Nephrology (19 citations). He Tian has collaborated with scholars based in China and United States. Frequent co-authors include Caiguo Huang, Wen‐Li Jiang, Wei Hao, Cuiting Lv, Chunxiang Li, Liyu Wang, Ruohua Chen, Tao Fan, Liyan Xue and Yujia Zheng. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.